These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 36567466)
1. UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial). Noaman S; Neil C; O'Brien J; Frenneaux M; Hare J; Wang B; Yee Tai T; Theuerle J; Shaw J; Stub D; Bloom J; Walton A; Duffy SJ; Peter KH; Cox N; Kaye DM; Taylor A; Chan W Eur Heart J Acute Cardiovasc Care; 2023 Apr; 12(3):143-152. PubMed ID: 36567466 [TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial. Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577 [TBL] [Abstract][Full Text] [Related]
3. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966 [TBL] [Abstract][Full Text] [Related]
4. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial. Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634 [TBL] [Abstract][Full Text] [Related]
5. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset. Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734 [TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305 [TBL] [Abstract][Full Text] [Related]
7. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI. Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885 [TBL] [Abstract][Full Text] [Related]
8. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction. Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956 [TBL] [Abstract][Full Text] [Related]
9. Platelet inhibition to target reperfusion injury trial: Rationale and study design. Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441 [TBL] [Abstract][Full Text] [Related]
18. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA; JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517 [TBL] [Abstract][Full Text] [Related]
19. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]). Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study. Pezel T; Besseyre des Horts T; Schaaf M; Croisille P; Bière L; Garcia-Dorado D; Jossan C; Roubille F; Cung TT; Prunier F; Meyer E; Amaz C; Derumeaux G; de Poli F; Hovasse T; Gilard M; Bergerot C; Thibault H; Ovize M; Mewton N Arch Cardiovasc Dis; 2020 Nov; 113(11):710-720. PubMed ID: 33160891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]